Human Genome Epidemiology Literature Finder
Records 1 - 16 (of 16 Records) |
Query Trace: Biliary Tract Neoplasms and KRAS[original query] |
---|
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 May 26 (5): 943-9. Chen J S, Hsu C, Chiang N J, Tsai C S, Tsou H H, Huang S F, Bai L Y, Chang I C, Shiah H S, Ho C L, Yen C J, Lee K D, Chiu C F, Rau K M, Yu M S, Yang Y, Hsieh R K, Chang J Y, Shan Y S, Chao Y, Chen L T, |
Molecular genomic landscapes of hepatobiliary cancer. Cancer science 2018 3 109 (5): 1282-1291. Shibata Tatsuhiro, Arai Yasuhito, Totoki Yasus |
Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers. American journal of cancer research 2018 2 8 (1): 2-15. Papadopoulou Kyriaki, Murray Samuel, Manousou Kyriaki, Tikas Ioannis, Dervenis Christos, Sgouros Joseph, Rontogianni Dimitra, Lakis Sotirios, Bobos Mattheos, Poulios Christos, Pervana Stavroula, Lazaridis Georgios, Fountzilas George, Kotoula Vassili |
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer. Cancer research and treatment 2018 Jan . Yoo Changhoon, Han Boram, Kim Hyeong Su, Kim Kyu-Pyo, Kim Deokhoon, Jeong Jae Ho, Lee Jae-Lyun, Kim Tae Won, Kim Jung Han, Choi Dae Ro, Ha Hong Il, Seo Jinwon, Chang Heung-Moon, Ryoo Baek-Yeol, Zang Dae You |
Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker. European journal of cancer (Oxford, England : 1990) 2019 Aug 120 31-39. Chae Heejung, Kim Deokhoon, Yoo Changhoon, Kim Kyu-Pyo, Jeong Jae Ho, Chang Heung-Moon, Lee Sang Soo, Park Do Hyun, Song Tae Jun, Hwang Shin, Kim Ki-Hun, Song Gi-Won, Ahn Chul Soo, Lee Jae Hoon, Hwang Dae Wook, Kim Song Cheol, Jang Se Jin, Hong Seung-Mo, Kim Tae Won, Ryoo Baek-Ye |
Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers. Acta oncologica (Stockholm, Sweden) 2019 12 59 (3): 298-301. Jensen Lars H, Andersen Rikke Fredslund, Byriel Lene, Fernebro Eva, Jakobsen Anders, Lindebjerg Jan, Nottelmann Lise, Ploen John, Hansen Torben |
Somatic Mutations from Whole Exome Sequencing Analysis of the Patients with Biliary Tract Cancer. Genomics & informatics 2019 1 16 (4): e35. Yoon Kyong-Ah, Woo Sang Myung, Kim Yun-Hee, Kong Sun-Young, Han Sung-Sik, Park Sang-Jae, Lee Woo J |
Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic Opportunities. Hepatology (Baltimore, Md.) 2020 Jan . Goeppert Benjamin, Folseraas Trine, Roessler Stephanie, Kloor Matthias, Volckmar Anna-Lena, Endris Volker, Buchhalter Ivo, Stenzinger Albrecht, Grzyb Krzysztof, Grimsrud Marit M, Gornicka Barbara, von Seth Erik, Reynolds Gary M, Franke Andre, Gotthardt Daniel N, Mehrabi Arianeb, Cheung Angela, Verheij Joanne, Arola Johanna, Mäkisalo Heikki, Eide Tor J, Weidemann Sören, Cheville John C, Mazza Giuseppe, Hirschfield Gideon M, Ponsioen Cyriel Y, Bergquist Annika, Milkiewicz Piotr, Lazaridis Konstantinos N, Schramm Christoph, Manns Michael P, Färkkilä Martti, Vogel Arndt, , Boberg Kirsten M, Schirmacher Peter, Karlsen Tom |
Actionability evaluation of biliary tract cancer by genome transcriptome analysis and Asian cancer knowledgebase. Oncotarget 2021 Jul 12 (15): 1540-1552. Okawa Yuki, Ebata Nobutaka, Kim Nayoung K D, Fujita Masashi, Maejima Kazuhiro, Sasagawa Shota, Nakamura Toru, Park Woong-Yang, Hirano Satoshi, Nakagawa Hidewa |
Risk of carcinogenesis in the biliary epithelium of children with congenital biliary dilatation through epigenetic and genetic regulation. Surgery today 2021 6 52 (2): 215-223. Mori Hiroki, Masahata Kazunori, Umeda Satoshi, Morine Yuji, Ishibashi Hiroki, Usui Noriaki, Shimada Mits |
Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations. International journal of cancer 2021 (1): 119-126. Amin Nadia Emad Lotfi, Hansen Torben Frøstrup, Fernebro Eva, Ploen John, Eberhard Jakob, Lindebjerg Jan, Jensen Lars Henr |
Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study. Frontiers in oncology 2022 9 12 988527. Takada Kohichi, Kubo Tomohiro, Kikuchi Junko, Yoshida Makoto, Murota Ayako, Arihara Yohei, Nakamura Hajime, Nagashima Hiroyuki, Tanabe Hiroki, Sugita Shintaro, Tanaka Yumi, Miura Ayana, Ohhara Yoshihito, Ishiguro Atsushi, Yokouchi Hiroshi, Kawamoto Yasuyuki, Mizukami Yusuke, Ohnishi Hirofumi, Kinoshita Ichiro, Sakurai Akihi |
Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation Sequencing. Cancers 2022 1 14 (1): . Csoma Szilvia Lilla, Bedekovics Judit, Veres Gerg?, Árokszállási Anita, András Csilla, Méhes Gábor, Mokánszki Atti |
The molecular landscape of pancreatobiliary cancers for novel targeted therapies from real-world genomic profiling. Journal of the National Cancer Institute 2022 May . Umemoto Kumiko, Yamamoto Hiroyuki, Oikawa Ritsuko, Takeda Hiroyuki, Doi Ayako, Horie Yoshiki, Arai Hiroyuki, Ogura Takashi, Mizukami Takuro, Izawa Naoki, Moore Jay A, Sokol Ethan S, Sunakawa |
ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer. Cancer research and treatment 2023 5 . Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, Beodeul Kang, Chan Kim, Hyo Sup Shim, Young Nyun Park, Sanghoon Jung, Sung Hoon Choi, Hye Jin Choi, Choong-Kun Lee, Hong Jae Ch |
Survival benefit and biomarker of PD-1 inhibitor combination therapy in first-line of advanced biliary tract cancer: A retrospective study. Cancer medicine 2023 11 . Jingyi Guo, Qun Zhou, Mingzhen Zhou, Hengheng Dai, Lin Li, Yudong Qiu, Liang Mao, Baorui Liu, Jie Sh |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: